IMMG Stock Chart

Immage Biotherapeutics Corp. is a biotechnology company, develops novel immunotherapy biologics to treat various cancers in the United States. It focuses on the development, marketing, and licensing of its patented immunotherapy candidate IMT-001, a hybrid/fusion protein vaccine that targets various tumors that express melanoma-associated antigen-A gene, including breast, liver, pancreas, prostate, melanoma, and lung diseases.